.:: Welcome to iQueueOnline ::.

Activity Detail

	ACTA: A Call to Action: Integrating Current Clinical Evidence in the Assessment and Treatment of Osteoporosis This activity has expired. The accredited provider can no longer issue certificates for this activity.

Program Overview Main Menu: Osteoporosis Therapeutics Analyzing the Data to Optimize Treatment The Diagnosis of Osteoporosis in Clinical Practice: A Practical Approach

Target Audience This activity has been designed to meet the educational need of healthcare providers in the diagnosis and management of patients with osteoporosis.

Learning Objectives Upon completion of this activity, participants should be better able to: Distinguish individuals at risk for osteoporotic fractures by identifying risk factors Recognize the high prevalence of vitamin deficiency and its consequences on skeletal and neuromuscular health Describe the role of bone densitometry in the diagnosis of osteoporosis and evaluation of treatment response Evaluate pharmacotherapies using evidence-based strategies

Faculty Christine SMDimonelli, MD Associate Clinical Professor of Medicine University of Minnesota Director, Osteoporosis Care HealthEast Clinics St. Paul, Minnesota Joseph M. Grisanti, M.D. Assistant Clinical Professor of Medicine, SUNY at Buffalo Chief of Rheumatology, Mercy Hospital of Buffalo Medical Director, Buffalo Rheumatology Associates President, Buffalo Osteoporosis Institute

Accreditation Statement This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of Creative Educational Concepts Foundation, Inc. and MedicoAlliance, LLC. Creative Educational Concepts Foundation, Inc. is accredited by the ACCME to provide continuing medical education for physicians.

Disclosure Declaration It is policy of Creative Educational Concepts Foundation, Inc. for individuals who are in a position to control the content of an educational activity to disclose to the learners all relevant financial relationships that they have with any commercial interest(s) that provide products or services that may be relevant to the content of this continuing medical education activity. Creative Educational Concepts, Foundation Inc. and MedicoAlliance, LLC report no relevant financial relationships with any commercial interests related directly or indirectly to the content of this educational activity. Christine Simonelli, MD Honoraria: Amgen Inc., NPS Pharmaceuticals, Merck & Co., Inc. Research Support: Novartis Pharmaceuticals, F. Hoffman-La Roche Ltd, Procter & Gamble Pharmaceuticals, Eli Lilly and Company, Merck & Co., Inc. Joseph Grisanti, MD Honoraria, Speaker Bureau and Consultant: F. Hoffman-La Roche Ltd, Procter & Gamble Pharmaceuticals, Eli Lilly and Company, Merck & Co. Inc., GlaxoSmithKline It is the policy of the accreditors to ensure independence, balance, objectivity, scientific rigor, and integrity in all of their continuing education activities.

Disclosure of Unlabeled Use The author, sponsor, and publisher of this continuing education activity have made all reasonable efforts to ensure that information contained herein is accurate in accordance with the latest available scientific knowledge at the time of accreditation. Information regarding drugs (e.g. their administration, dosages, contraindications, adverse reactions, interactions, special warning, precautions) and drug delivery systems is subject to change; however, and the reader is advised to check the manufacturer’s package insert for information concerning recommended dosage and potential problems or cautions prior to dispensing or administering the drug or using the drug delivery system. The faculty has indicated that there will not be any discussion of unapproved uses in their presentations.